Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001853053 | SCV002235638 | pathogenic | not provided | 2021-02-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu725Glyfs*25) in the NPHS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHS1 are known to be pathogenic (PMID: 11317351, 11854170, 12039988). This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with nephrotic syndrome (PMID: 16703378). ClinVar contains an entry for this variant (Variation ID: 56466). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000049879 | SCV004191494 | pathogenic | Finnish congenital nephrotic syndrome | 2022-11-08 | criteria provided, single submitter | clinical testing | |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000049879 | SCV000082288 | likely pathogenic | Finnish congenital nephrotic syndrome | no assertion criteria provided | not provided | Converted during submission from probable-pathogenic to Likely pathogenic. | |
Department of Traditional Chinese Medicine, |
RCV000049879 | SCV002599093 | pathogenic | Finnish congenital nephrotic syndrome | no assertion criteria provided | research |